MEDVi vs Noom Med: Which GLP-1 Provider Is Better?
Short answer: Noom Med scores higher on our rubric, 7.4/10 against 5.7/10. Full reasoning, pricing and the cases where the other one wins are below.
Noom Med beats MEDVi overall, scoring 7.4/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; Noom Med is $79 first month, then $199/mo. Choose MEDVi for users who want both oral and injectable compounded options in one telehealth program. Choose Noom Med for users who want a low-dose glp-1 with biomarker monitoring and can absorb the step from a $79 starter to $199/mo ongoing.
A side-by-side look at MEDVi and Noom Med to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
MEDVi
#46 of 54MEDVi offers oral and injectable compounded GLP-1 care. Semaglutide is $179 for month one and $299 for refills. Trustpilot is 4.4/5 across roughly 11,000 reviews, while BBB is F/not accredited. FDA warning letter #721455 concerns misleading labeling and marketing, not an allegation that the medication was unsafe.
Visit MEDViNoom Med
#23 of 54Noom restructured Noom Med in 2026 into a GLP-1 ladder plus a non-GLP-1 pill: Microdose GLP-1Rx at $79 then $199/mo, GLP-1Rx at $129 then $249/mo, GLP-1Rx Plus at $149 then $299/mo, and a metformin pill at $69 then $99/mo that is not a GLP-1. Verified 2026-07-27. Historic note: the Full GLP-1Rx program ($149 intro → $349/mo on 12-week subscription). Coaching app included at every tier.
Visit Noom Med| Feature | MEDVi | Noom Med |
|---|---|---|
| Why each one | Oral and injectable compounded formats in one program, with micro-dosing options and a path to FDA-approved brand medication. | The only GLP-1 platform built on a decade of behavioral psychology research, combining medication with Noom's proven coaching methodology for lasting habit change. |
| Our Score | 5.7/10 | 7.4/10 |
| Headline Price | $179 first month, then $299/mo | $79 first month, then $199/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | Yes |
| Best For | Users who want both oral and injectable compounded options in one telehealth program | Users who want a low-dose GLP-1 with biomarker monitoring and can absorb the step from a $79 starter to $199/mo ongoing |
| Watch out for | FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication | Tiered pricing is genuinely confusing, and the cheapest advertised tier ($69 then $99/mo) is metformin rather than a GLP-1, which is easy to mistake for the GLP-1 entry price [Verified 2026-07-27] |
| Ranking | #46 | #23 |
| Get started | Visit MEDVi | Visit Noom Med |
Pros & Cons Compared
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179 covers the first month of compounded semaglutide on the current Katalys landing, including clinician review, medication and shipping
Cons
- −FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
- −Its third-party records conflict: 4.4/5 across roughly 11,000 Trustpilot reviews, but an F and no accreditation at the BBB
- −The $179 semaglutide price is introductory; the current Katalys landing says refills are $299/mo, making the first-year total $3,468 rather than $2,148
- −Brand-name Wegovy and Zepbound paths add a $99 membership plus the medication cost, which the current landing does not publish; availability can change
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Noom Med
Pros
- +Tiered 2026 entry, $69/mo branded telehealth tier lets users start with just medication access and the coaching app
- +Microdose GLP-1Rx is $79 for the first 4 weeks then $199/mo billed quarterly, low-dose GLP-1 plus biomarker monitoring for side-effect-sensitive users [Verified 2026-07-27]
- +Insurance accepted for qualifying plans, can significantly reduce out-of-pocket costs on brand-name meds
- +Industry-leading behavioral coaching app with years of psychology-based weight loss methodology
Cons
- −Tiered pricing is genuinely confusing, and the cheapest advertised tier ($69 then $99/mo) is metformin rather than a GLP-1, which is easy to mistake for the GLP-1 entry price [Verified 2026-07-27]
- −Full GLP-1Rx program requires 12-week subscription ($149 intro rate applies only for the first few weeks)
- −Medication costs on the $69 tier are out-of-pocket, the low tier price is just the platform
- −App coaching still requires real engagement, skip-prone users waste the behavioral value
Our Verdict
Noom Med edges out MEDVi with a score of 7.4/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; Noom Med is $79 first month, then $199/mo. Noom Med accepts insurance, which can significantly reduce your out-of-pocket costs.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving MEDVi and Noom Med.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- MEDVi vs Foundpublished $129/mo; total not verified
- MEDVi vs Oak Longevityfrom $119/mo
- MEDVi vs Fridays$249/mo month-to-month
- Noom Med vs Elevate Healthfrom $233/mo
- Noom Med vs FeelGoodfrom $149/mo
- Noom Med vs Maximuspublished $79.99/mo; total not verified
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: Noom Med · 7.4/10